USA - engelska - NLM (National Library of Medicine)

baxter healthcare corporation - naloxone hydrochloride (unii: f850569pqr) (naloxone - unii:36b82amq7n) - naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids, including propoxyphene, methadone and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine. naloxone hydrochloride injection is also indicated for diagnosis of suspected or known acute opioid overdosage. naloxone hydrochloride injection may be useful as an adjunctive agent to increase blood pressure in the management of septic shock (see clinical pharmacology; adjunctive use in septic shock ). naloxone hydrochloride injection is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients contained in the formulation. naloxone hydrochloride is an opioid antagonist. physical dependence associated with the use of naloxone hydrochloride has not been reported. tolerance to the opioid antagonist effect of naloxone hydrochloride is not known to occur.

USA - engelska - NLM (National Library of Medicine)

baxter healthcare corporation - naloxone hydrochloride (unii: f850569pqr) (naloxone - unii:36b82amq7n) - naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids, including propoxyphene, methadone and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine. naloxone hydrochloride injection is also indicated for diagnosis of suspected or known acute opioid overdosage. naloxone hydrochloride injection may be useful as an adjunctive agent to increase blood pressure in the management of septic shock (see clinical pharmacology; adjunctive use in septic shock ). naloxone hydrochloride injection is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients contained in the formulation. naloxone hydrochloride is an opioid antagonist. physical dependence associated with the use of naloxone hydrochloride has not been reported. tolerance to the opioid antagonist effect of naloxone hydrochloride is not known to occur.

USA - engelska - NLM (National Library of Medicine)

medical purchasing solutions, llc - naloxone hydrochloride (unii: f850569pqr) (naloxone - unii:36b82amq7n) - naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids, including propoxyphene, methadone and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine. naloxone hydrochloride injection is also indicated for diagnosis of suspected or known acute opioid overdosage. naloxone hydrochloride injection may be useful as an adjunctive agent to increase blood pressure in the management of septic shock (see clinical pharmacology; adjunctive use in septic shock ). naloxone hydrochloride injection is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients contained in the formulation. naloxone hydrochloride is an opioid antagonist. physical dependence associated with the use of naloxone hydrochloride has not been reported. tolerance to the opioid antagonist effect of naloxone hydrochlo

Irland - engelska - HPRA (Health Products Regulatory Authority)

generics (uk) limited - naloxone hydrochloride dihydrate; oxycodone hydrochloride - prolonged-release tablet - 5 / 2.5 milligram(s) - natural opium alkaloids; oxycodone, combinations

Irland - engelska - HPRA (Health Products Regulatory Authority)

generics (uk) limited - naloxone hydrochloride dihydrate; oxycodone hydrochloride - prolonged-release tablet - 40 / 20 milligram(s) - natural opium alkaloids; oxycodone, combinations

Irland - engelska - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - naloxone hydrochloride dihydrate; oxycodone hydrochloride - prolonged-release tablet - 20mg /10 milligram(s) - natural opium alkaloids; oxycodone, combinations

Irland - engelska - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - naloxone hydrochloride dihydrate; oxycodone hydrochloride - prolonged-release tablet - 5 mg/ 2.5 milligram(s) - natural opium alkaloids; oxycodone, combinations

Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - oxycodone hydrochloride 20 mg; naloxone hydrochloride dihydrate 10,9 mg - eq. naloxone hydrochloride 10 mg - prolonged-release tablet - 20 mg - 10 mg - oxycodone hydrochloride 20 mg; naloxone hydrochloride dihydrate 10.9 mg - oxycodone, combinations

Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - oxycodone hydrochloride 30 mg; naloxone hydrochloride dihydrate 16,35 mg - eq. naloxone hydrochloride 15 mg - prolonged-release tablet - 30 mg - 15 mg - oxycodone hydrochloride 30 mg; naloxone hydrochloride dihydrate 16.35 mg - oxycodone, combinations

Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - oxycodone hydrochloride 10 mg; naloxone hydrochloride dihydrate 5,45 mg - eq. naloxone hydrochloride 5 mg - prolonged-release tablet - 10 mg - 5 mg - oxycodone hydrochloride 10 mg; naloxone hydrochloride dihydrate 5.45 mg - oxycodone, combinations